Compare Humana Inc (HUM) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs The Coca-Cola Co K — how do they compare? Humana Inc trades at $404.09 (market cap $47.81B), while The Coca-Cola Co K trades at $81.9 (market cap $353.32B). The key difference: The Coca-Cola Co K is far larger — about 7.4× Humana Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.58%). Which is the better fit depends on your goals.
| HUM | KO | |
|---|---|---|
Market Cap | $47.81B | $353.32B |
Sector | Health | Consumer Staples |
52-Week High | $409.42 | $84.92 |
52-Week Low | $163.67 | $65.67 |
Enterprise Value | $56.85B | $383.39B |
Dividend Yield | 0.89% | 2.58% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Coca-Cola (KO) trades at $81.74, up 0.22% today, with a bearish technical signal but strong fundamentals including 27.8% net margin and consistent earnings beats. The stock shows robust profitability with ROE at 45.8% and positive cash flow trends, supported by a $0.53 quarterly dividend. Recent news highlights institutional buying and stable demand ahead of Q2 2026 earnings.
Outlook remains positive with a $90.67 consensus price target implying 11% upside, though risks include regional demand divergence and high debt. Analyst sentiment is bullish (60% Buy), but technical resistance near $83 may limit near-term gains. Long-term investors may find value in KO's dividend stability and brand strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
